Meet the biotech shooting to be Bay Area's 10th life sciences IPO this year
August 20, 2018 at 16:39 PM EDT
The 10-year-old company made a big splash last year with a potential multiple sclerosis drug deal with Sanofi. But it also has programs targeting inflammatory skin conditions and cancer.
